Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Perennial Allergic Rhinitis (PAR)

Clinical trial NCT01244217 · COMPLETED

Trial details

NCT number: NCT01244217
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Rhinitis Perennial

Start date: 2010-10-01
Primary completion: 2011-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.